BackCrinetics Pharmaceuticals Overview

Crinetics Pharmaceuticals Inventory

Crinetics Pharmaceuticals's inventory is $3.5M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$3.49M

Peer trimmed avg / median

Loading

Crinetics Pharmaceuticals Inventory History

Loading

Crinetics Pharmaceuticals vs. peers: Inventory Comparison

Loading

Crinetics Pharmaceuticals Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Crinetics Pharmaceuticals (CRNX) FAQ

As of the most recent data (June 2026), CRNX shows a inventory of $3.5M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CRNX's inventory is now $3.5M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Crinetics Pharmaceuticals is outperforming or lagging.

Tracking CRNX's inventory over time shows whether Crinetics Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $3.5M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Crinetics Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $3.5M) with ownership activity and broader fundamentals.

Crinetics Pharmaceuticals's inventory is $3.5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.